These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9409083)

  • 1. Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
    Klein E; Malel D; Zilberman I; Lenox RH
    Isr J Psychiatry Relat Sci; 1997; 34(4):265-9. PubMed ID: 9409083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized anxiety disorder versus panic disorder: participation in controlled efficacy trials.
    Mavissakalian MR; Zamar N
    Compr Psychiatry; 2000; 41(4):253-8. PubMed ID: 10929792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
    J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
    Tesar GE
    J Clin Psychiatry; 1990 May; 51 Suppl():4-10; discussion 50-3. PubMed ID: 1970816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
    Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
    Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
    Herman JB; Brotman AW; Rosenbaum JF
    J Clin Psychiatry; 1987 Oct; 48 Suppl():22-8. PubMed ID: 2889722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of sustained release of alprazolam: A naturalistic study].
    De La Gándara Martín JJ; Sanz Granado O; Varona Martínez A; Such P
    Actas Esp Psiquiatr; 1999; 27(3):191-7. PubMed ID: 10431062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    Klein E; Colin V; Stolk J; Lenox RH
    Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
    Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical effect of alprazolam and trazodone on bronchial asthmatics with anxiety disorder].
    Haida M; Itoh K
    Arerugi; 1997 Oct; 46(10):1058-71. PubMed ID: 9404094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care.
    Rollman BL; Belnap BH; Mazumdar S; Houck PR; Zhu F; Gardner W; Reynolds CF; Schulberg HC; Shear MK
    Arch Gen Psychiatry; 2005 Dec; 62(12):1332-41. PubMed ID: 16330721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
    Pollack MH; Otto MW; Tesar GE; Cohen LS; Meltzer-Brody S; Rosenbaum JF
    J Clin Psychopharmacol; 1993 Aug; 13(4):257-63. PubMed ID: 8376613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    Hoehn-Saric R; McLeod DR; Zimmerli WD
    J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.